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1119-59 Measurement of Myocardial Infarct Size in Mice Using 
Pinhole Single Photon Emission Computed 
Tomogrsphy 
Max C. Wu, Richard E. Sievers, Dong Wei Gad, Randall J. Lee, Bruce H. Hasegawa, 
Michael W. Dae. University of California San Francisco, San Francisco, Cafifomia. 
Background: The transgenic mouse has become a dominant model to assess myocar- 
dial disease; however, physiologic measurements are often difficult to perform. We 
assessed the feasibility of noninvasively measuring myocardial infarct size in murine 
myocardium. 
Methods: We constructed a single photon emission computed tomography (SPECT) 
system capable of producing clinical quality myocardial perfusion images of mice. The 
system consists of a scintillation camera with a 1 mm pinhote collimator that produces a 
magnified image of the object. Objects are rotated vertically in front of the camera to 
acquire tomographic projection data. We performed phantom studies to assess the sys- 
tem spatial resolution, sensitivity, and uniformity for a variety of magnification factors. 
Control myocardial perfusion studies (n=6) were performed using BALB/c mice (18-23 g). 
Mice were anesthetized, injected with 7-14 mCi of 99mTc-sestamibi, and imaged in a cus- 
tom designed plastic tube. After a 20 minute SPECT acquisition, mice were sacrificed, 
and their heads were removed, frozen, and sectioned for autoradiography of 99rnTc. The 
left anterior descending coronary artery in the study group (n=11) was permanently 
ligated to create acute myocardial infarction. The chest was closed, and the mice were 
imaged according to the control protocol, followed by autoradiography. 
Reaults: Five representative short-axis slices were chosen from each SPECT image, 
and regional perfusion was quantified using circumferential profile analysis, where the 
maximum intensity along rays from the center of the slice was plotted as a function of 
angle. The threshold, derived from the control studies, for determining whether an angu- 
lar sample was part of the infarct was set at 50% of the maximum intensity. For each 
mouse, the % infarcted myocardium was determined from the SPECT image and corre- 
lated to an area fraction measurement derived from autoradiography. The correlation 
coefficient r=0.80 was significant o a level of p<0.005. 
Conclusion: Noninvasive quantitative assessment of myocardial perfusion defect size is 
feasible in murine myocardium. This methodology may allow serial assessment of novel 
interventions to reduce infarct size. 
1119-60 Evidence for Increased Angiotenain II Type I Receptor 
Immunoreectivity in Peri-lnfarct Myocardium of Human 
Explanted Hearts 
Vasken Dilsizian. Maria Loredo, Victor J. Fsrrans, Elaine M. Jagoda, William C. 
Eckelman, Jamshid Shirani, University of Maryland Medics~ Center, Baltimore, Maryland, 
National Institutes of Health, Bethesda, Maryland. 
Background: Upregulation of angiotansin-conveding enzyme (ACE) has been implicated 
in left ventricular (LV) remodeling and fibrosis in heart failure. We recently synthesized a 
new radiotracar, [18F]fluorobenzoyl-lisinopril, which showed specific binding to ACE in 
human heads with ischemic cardiemyopathy (I-CMP). [18F]fluorobenzoyl-lisinopril bind- 
ing was nonuniform in infarct and noninfarct segments, with increased binding in areas 
adjacent o replacement fibrosis. If upregulation of ACE is reversible, e.g,, by ACE inhibi- 
tors, noninvasive imaging with PET may allow monitoring the effects of medical and/or 
interventional therapy on disease progression. Methods: We applied the peroxidase 
method to examin e histochemically the distribution of angiotensin II receptors (AnglI-R) 
in normal, infarct and peri-infarct myocardium, and in the heads of patients (n = 3) with I- 
CMP. A polyclonal antibody against the human Angll AT1 receptor (Santa Cruz Biotech- 
nology, Inc.) was used (1:100 dilution) in conjunction with the Vectastain Elite ABC kit. 
For antigen retrieval, 5 to 10 mm-thick sections were immersed in a 0.4% pepsin solution 
in 0.1 N HCI for 10 min at 37oC, followed by blocking with 2% bovine serum albumin and 
10% normal goat serum. The sections were then incubated overnight with Anglt anti- 
body. Bronchial and vascular smooth muscle cells from lung tissue of patients without 
pulmonary disease served as positive controls. Results: In noninfarct myocardium, Angll- 
R immunoreactivity was confined to smooth muscle and eodothalium. Myocytes were 
unreactive. In contrast, in peri-infarct myocardium, there was increased immunoreactivity 
for AngH-R, which was localized in the myooytes. Although some AnglI-R immunoreactiv- 
ity was also seen in infarct myocardium, it was localized predominantly in fibroblasts or 
within islands of surviving myocytes. Conclusion: These data confirm our previous quan- 
titative autoradiographic observations concerning [18F]fiuorobenzoyl-lisinopril binding in 
normal, infamt and peri-infarct myocardium. The immunoreactivity for AnglI-R in the peri- 
infarct and infarct myocardium suggests a role of Angll in LV remodeling and fibrosis in 
chronic I-CMP. 
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1119-61 Reduced Metabolic Reserve in Both Right and Left 
Ventricles in Patients With Heart Failure 
Heikki Ukkonen, Rob Seanlaods, Juhani Knuuti, Liisa-Maria Voipio-Pulkki, Turku PET 
Centre, Turku, Finland, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. 
Background: In patients with congestive heart failure (CHF), right ventricular (RV) func- 
tion contributes to exercise tolerance and also carries prognostic value. Oxidative metab- 
olism (OM) reserve may be impaired in these patients. However, the OM in the RV is 
poorly characterized in CHF patients. 11C-acetate PET imaging allows assessment of 
OM in both LV and RV simultaneously. 
Subjects and methods: LV and RV oxidative metabolism was assessed in 5 male 
patients with CAD and LV dysfunction (LVEF 30~3 %, NYHA Class 2 to 3) and in 5 
healthy male volunteers using the clearance rate constant (kmono) from 11C-acetate PET 
imaging at rest and during dobutamine infusion (5-7.5 microg/kg/min). 
Results: In HV dobutamine increased OM by 100% in RV (krnono: 0.04210.004 to 
0,084-+0.008, p=0.002) and by 58% in LV (0.064:L-0.008 to 0.100~0.010, p=0.002), RV 
OM increased relatively more as RV/LV krnon o ratio increased by 27% (67_+3 to 84±4 %, 
p=O.004). In CHF patients the responses were blunted: RV kmono 0.054-+0.017 vs. 
0.067±0.010, LV kmono 0.8581-0.007 vs. 8,067_+0.012 and RV/LV krnon o ratio 95±33 % vs. 
102+18%, p=NS. Baseline RV/LV kmono ratio was higher in CHF patients (p=8,059) 
Conclusions: In healthy hearts dobutamine increases RV/LV ratio by 27 %, which 
emphasizes the role of the RV in normal response to stress. In patients with CAD and LV 
dysfunction the metabolic response to dobutamine is impaired and the RV/LV kmono ratio 
is elevated suggesting an imbalance in RV and LV metabolism,11C-ecetate PET allows 
the assessment of RV oxidative metabolism relative to the LV which may be an important 
alteration in CHF. 
1119-62 Comparison of the Prognostic Value of Cardiac 1-123 
Metaiodobenzylguanidine Imaging and Heart Rate 
Variabil ity in Patients With Mild to Moderate Chronic 
Heart Failure 
Takahisa Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, Kazuaki Kumagai, Akio 
Hirata, Mitsutoshi Asai, Nobuhiko Makino, Hidataka Kioka, Noritake Hoki, Osaka 
Prefectural General Hospital, Osaka, Japan. 
Background: Cardiac 1-123 metaiodobenzylguanidine (MIBG) images, which would 
reflect the cardiac adrenergic nerve activity, provide prognostic information in patients 
with chronic heart failure (CHF). Reduced heart rate variability (HRV), indicating 
derangement in cardiac autonomic ontrol, was also reported to be associated with poor 
prognosis in CHF patients. No information is available on the comparison of the prognos- 
tic value of MIBG and HRV in CHF patients. 
Methods: At the entry, MIBG imaging and 24 hour Holter monitorings were performed in 
65 stable outpatients with CHF (NYHA: 2.0-+0.6, ischemic origin: 83%) whose radionu- 
clide left ventricular ejection fraction was less than 40% (28+8%). The cardiac MIBG 
heart to madiastinum ratio (H/M) and washout rate (WR) were calculated from the chest 
anterior view images obtained at 20 and 200 min after isotope injection. The time and fre- 
quency domain parameters of HRV were calculated from 24 hour Halter recordings. 
Results: During the follow-up period of 34±19 months, 13 of 65 patients had cardiac 
events (death [n=4], hospitalization for worsening CHF [n=9]). At univariata Cox analysis, 
out of the variables including clinical, echocardiogrphic, hemodynamic, biochemical, 
MIBG and HRV parameters, WR (p<8.0001), H/M(delayed) (p=0.01), normalized very 
low frequency (n-VLF: 0.003-0.04 Hz) power (p=0.04), left atrial dimension (p=0.006) and 
plasma noradrenaline level (p=0.01) showed a significant association with the cardiac 
events. At multivariate Cox analysis, WR was an independent predictor of the cardiac 
events (p=0.029, hazard ratio 1.072 [95%CI 1.007-1.14]). Risk ratio of cardiac events in 
patients with abnormal WR (>27%: mean+2SD obtained from 20 normal controls) was 
6.0 (95%CI 1.5 to 25.1), which was greater than risk ratio (3.9 [95%C1 1.5 to 10.3]) in 
patients with abnormal n-VLF power (<22: mean-2SD obtained from normal controls). 
Kaplan-Meier analysis revealed that the cardiac events were significantly more often 
observed in patients with than without abnormal WR (36% vs 6%, p=0.001). 
Conclusion: MIBG washout rate has higher prognostic value than HRV parameters in 
patients with mild to moderate CHI~ 
1119-63 B1-Adrenergic Receptor Gene Polymorphism 
Modulates Cardiac Sympathetic Innervation in Patients 
With Dilated Cardiomyopathy 
Chikao Iwai. Hozuka Akita, Nobuyuki Shiga, Eiji Takai, Yoshitomo Miyamoto, Masakatsu 
Shimizu, Sei Fujiwara, Hiroya Kawai, Shin-ichioro Yamada, Akira Takarada, Teishi 
Kajiya, Mitsuhiro Yokoyama, Division of Cardiovascular and Respiratory Medicine, Kobe 
University Graduate School of Medicine, Kobe, Japan, Department of Cardiology, Himaji 
Cardiovascular Center, Himeji, Japan. 
Background: Iodine 123-metaiodebenzylguanidine (MIBG) is a tracer for imaging of car- 
diac sympathetic (CS) innervafion. Many studies reported that MIBG scintigrphy was a 
useful noninvasive method for the assessment of prognosis of Dilated Cardiomyopathy 
(DCM). In addition, CS function estimated by MIBG imaging has shown to be the predic- 
tor of favorable response to ~,-blockers (including ~1 selective) in DCM, implying the 
interaction of ~l-adrenergic receptor ([]IAR) function with CS innervation in heart failure. 
Recently, a common functional ~IAR gene polymorphism (Arg389Gly) has been identi- 
fied. In vitro functional assays revealed that adenylyl cyclase activities for the Arg389 
were 3 times higher than those for the Gly389 with agonist stimulation. Hence, we spec- 
ulate that Arg389 may induce more prominent CS dysfunction compared with Gly389 in 
DCM. 
Methods: in 54 Japanese patients with DCM (40 men, 58,9±1.5 years, left ventricular 
ejection fraction (EF); 31.4+1.5%), we studied MIBG imaging and gene analysis for the 
genotyping as described previously, The heart to mediastinum MIBG uptake ratio (H/M) 
